-
Drosophila Keap1, Lamin, and Nuclear Architecture
2026-08-15
Carlson and colleagues identify a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, linking xenobiotic-response signaling to nuclear lamina organization and heterochromatin distribution. Their genetic, localization, and chromatin-based evidence suggests that dKeap1 influences development partly by regulating higher-order nuclear architecture rather than only by controlling detoxification transcripts.
-
Hexa His Tag Peptide: Clean IP Elution Workflow
2026-08-14
The Hexa His tag peptide enables gentle, antibody-compatible elution of 6X His fusion proteins without introducing antibody heavy- and light-chain contamination. This practical workflow shows how to apply competitive elution to protein purification and protein interaction analysis, including assays inspired by recent CARMIL membrane-binding research.
-
Olaparib (AZD2281) in DNA Damage Assays
2026-08-14
Olaparib (AZD2281) provides a precise way to interrogate PARP1/2 dependence in BRCA-deficient models, platinum-resistant ovarian cancer, and radiation-response experiments. This workflow connects the CLK2–BRCA1 repair axis to practical combination assays while emphasizing controls, exposure timing, and troubleshooting.
-
DAF-2 Diacetate Maps NO in Soybean Nodule Senescence
2026-08-13
A translational framework for using DAF-2 diacetate to connect sulfur supply, reactive nitrogen species, and soybean nodule senescence while preserving the assay’s mechanistic and analytical limitations.
-
10074-G5 for Reproducible c-Myc Assays
2026-08-13
This scenario-based guide explains how 10074-G5 (SKU C5722) can be incorporated into cell viability, apoptosis, and cell-cycle experiments while controlling solvent, dose, storage, and interpretation variables. It connects product specifications with reported c-Myc biology and provides practical selection criteria for cancer research workflows.
-
Protease Inhibitor Cocktail for Lipid Studies
2026-08-12
Protect DFCP1, ATGL, and lipid-droplet proteins from extraction artifacts with a broad-spectrum, water-soluble protease mixture. This workflow shows when EDTA-containing inhibition improves Western blot, Co-IP, imaging, and enzymatic assays—and when EDTA must be removed or avoided.
-
CHIR-99021: GSK-3 Control for Stem Cell Translation
2026-08-12
A mechanistic and translational framework for using CHIR-99021 (CT99021) to control Wnt/β-catenin biology, interpret pluripotency phenotypes, and design more decision-ready stem cell experiments.
-
URB597 Workflows for Endocannabinoid Research
2026-08-11
Build cleaner FAAH-mechanism experiments with URB597, from brain-membrane assays to behavioral pain models. This workflow-focused guide shows how KDS-4103 can complement cannabidiol studies by separating FAAH-dependent anandamide elevation from broader endocannabinoid and affective effects.
-
Vernakalant Injection for Rapid AF Conversion
2026-08-11
The ACT-III trial evaluated RSD1235, or vernakalant hydrochloride injection, as a rapid intravenous strategy for converting recent-onset atrial fibrillation to sinus rhythm. Its randomized, placebo-controlled design showed markedly higher conversion rates and a median response time of 8 minutes in short-duration AF, while also defining important safety and patient-selection considerations.
-
DiscoveryProbe Protease Inhibitor Library: Assay Logic
2026-08-10
The DiscoveryProbe Protease Inhibitor Library supports a decision-driven approach to protease inhibition, from phenotypic screening to mechanistic validation. This article explains how evidence from plant guard-cell biology can sharpen assay design without overextending cross-domain conclusions.
-
Bazedoxifene Workflows for ER Signaling Research
2026-08-09
Bazedoxifene enables controlled interrogation of estrogen receptor signaling, from MCF7 transcription assays to bone-loss models. This workflow-focused guide covers dose design, tissue-selective interpretation, comparative SERM analysis, and troubleshooting for reproducible osteoporosis treatment research.
-
Deferasirox Fe3+ Chelate: Research Workflows
2026-08-08
Build reproducible iron-chelation assays around a defined ferric complex, with practical controls for DMSO solubility, speciation, and cell exposure. The workflow separates clinically established Exjade concepts from bench hypotheses, helping researchers interpret iron-mobilization data without overstating a research reagent’s medical role.
-
Oligo (dT) 25 Beads for Translational RNA
2026-08-07
Mechanistic cancer biology depends on RNA measurements that preserve biological signal. This thought-leadership guide connects polyA-selected mRNA workflows with evidence on PLPP1-mediated phospholipid synthesis and cisplatin resistance, offering practical guidance for designing reproducible translational experiments.
-
Gut-Brain Cholinergic Circuits in Microbiota-Mediated Seizur
2026-08-07
Jia et al. reveal that Bacteroides fragilis suppresses seizures via enhanced gut-brain cholinergic signaling, mediated by colonic ChAT+ cells and the vagus nerve. Their combined preclinical and clinical approach establishes a mechanistic basis for microbiota-targeted therapy in refractory epilepsy.
-
Bazedoxifene: Mechanistic Insight and Strategy for Translati
2026-08-06
This thought-leadership article delivers a deep mechanistic and strategic exploration of Bazedoxifene’s dual role as a selective estrogen receptor modulator and an emerging inhibitor of IL-6/GP130 signaling. It contextualizes Bazedoxifene’s applications for postmenopausal osteoporosis and cancer pathway research, offering protocol guidance and translational perspectives for researchers seeking to bridge preclinical discovery with clinical innovation.